期刊
CELL METABOLISM
卷 31, 期 2, 页码 284-+出版社
CELL PRESS
DOI: 10.1016/j.cmet.2019.11.002
关键词
-
资金
- Bloomington Stock Center [NIH P40OD018537]
- Nora Eccles Treadwell Foundation
- [1S10OD016232-01]
- [1S10OD021505-01]
- [1S10OD01821001A1]
- [R01CA228346]
- [1F30CA225110-01]
- [4T32HD007491-21]
- [4R00CA215307-03]
- [1T32DK11096601]
Although metabolic adaptations have been demonstrated to be essential for tumor cell proliferation, the metabolic underpinnings of tumor initiation are poorly understood. We found that the earliest stages of colorectal cancer (CRC) initiation are marked by a glycolytic metabolic signature, including downregulation of the mitochondrial pyruvate carrier (MPC), which couples glycolysis and glucose oxidation through mitochondrial pyruvate import. Genetic studies in Drosophila suggest that this downregulation is required because hyperplasia caused by loss of the Apc or Notch tumor suppressors in intestinal stem cells can be completely blocked by MPC overexpression. Moreover, in two distinct CRC mouse models, loss of Mpcl prior to a tumorigenic stimulus doubled the frequency of adenoma formation and produced higher grade tumors. MPC loss was associated with a glycolytic metabolic phenotype and increased expression of stem cell markers. These data suggest that changes in cellular pyruvate metabolism are necessary and sufficient to promote cancer initiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据